1. Home
  2. CRBU vs FNKO Comparison

CRBU vs FNKO Comparison

Compare CRBU & FNKO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CRBU
  • FNKO
  • Stock Information
  • Founded
  • CRBU 2011
  • FNKO 2017
  • Country
  • CRBU United States
  • FNKO United States
  • Employees
  • CRBU N/A
  • FNKO N/A
  • Industry
  • CRBU Medicinal Chemicals and Botanical Products
  • FNKO Recreational Games/Products/Toys
  • Sector
  • CRBU Health Care
  • FNKO Consumer Discretionary
  • Exchange
  • CRBU Nasdaq
  • FNKO Nasdaq
  • Market Cap
  • CRBU 203.9M
  • FNKO 170.7M
  • IPO Year
  • CRBU 2021
  • FNKO 2017
  • Fundamental
  • Price
  • CRBU $2.08
  • FNKO $3.32
  • Analyst Decision
  • CRBU Strong Buy
  • FNKO Buy
  • Analyst Count
  • CRBU 3
  • FNKO 4
  • Target Price
  • CRBU $9.33
  • FNKO $7.13
  • AVG Volume (30 Days)
  • CRBU 4.6M
  • FNKO 852.6K
  • Earning Date
  • CRBU 11-07-2025
  • FNKO 11-06-2025
  • Dividend Yield
  • CRBU N/A
  • FNKO N/A
  • EPS Growth
  • CRBU N/A
  • FNKO N/A
  • EPS
  • CRBU N/A
  • FNKO N/A
  • Revenue
  • CRBU $9,121,000.00
  • FNKO $928,842,000.00
  • Revenue This Year
  • CRBU $8.06
  • FNKO N/A
  • Revenue Next Year
  • CRBU N/A
  • FNKO $10.57
  • P/E Ratio
  • CRBU N/A
  • FNKO N/A
  • Revenue Growth
  • CRBU N/A
  • FNKO N/A
  • 52 Week Low
  • CRBU $0.66
  • FNKO $2.22
  • 52 Week High
  • CRBU $3.54
  • FNKO $14.65
  • Technical
  • Relative Strength Index (RSI)
  • CRBU 39.13
  • FNKO 54.83
  • Support Level
  • CRBU $2.28
  • FNKO $2.93
  • Resistance Level
  • CRBU $3.53
  • FNKO $3.18
  • Average True Range (ATR)
  • CRBU 0.27
  • FNKO 0.20
  • MACD
  • CRBU -0.07
  • FNKO 0.03
  • Stochastic Oscillator
  • CRBU 7.81
  • FNKO 47.76

About CRBU Caribou Biosciences Inc.

Caribou Biosciences Inc is a clinical-stage Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) biopharmaceutical company dedicated to transforming the lives of patients with devastating diseases by applying its novel CRISPR platform, CRISPR hybrid RNA-DNA (chRDNA), toward the development of next-generation, genome-edited cell therapies. The company operates and manage business as one reportable operating segment, which is the business of developing a pipeline of allogeneic CAR-T and CAR-NK cell therapies. Geographically, it operates in United States and Rest of the World, of which United States derives maximum revenue.

About FNKO Funko Inc.

Funko Inc is an USA based pop culture consumer products company. It creates whimsical, fun, and different products that enable the customer to express their affinity for their favorite through the movie, TV show, video game, musician, or sports team. The company's current products are principally figures, fashion accessories, apparel, plush products, accessories, homewares, and NFTs. The company sells its products through a diverse network of retail customers across multiple retail channels, including specialty retailers, mass-market retailers, and e-commerce sites. The company generates the majority of its revenue from the core collectibles products.

Share on Social Networks: